Search
for
Sort by
Research 151–180 of 1000+
- Chinese Experts Consensus on the Management of Uncommon Dermatophytosis
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Peritoneal reactions with some of the tubal occlusive agents.
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- PD57-09 NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM SURGICAL RISK CALCULATOR POORLY PREDICTS COMPLICATIONS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH URINARY DIVERSION: THE CASE FOR A PROCEDURE-SPECIFIC RISK CALCULATOR
- Development of a Novel Mouse Model for Hair Regeneration Using Glue-like Adhesive Materials
- Platelet-Rich Plasma for Treating Androgenic Alopecia: A Systematic Review
- Adrenocorticotropic Hormone (ACTH) But Not Alpha-Melanocyte Stimulating Hormone (a-MSH) as a Mediator of Adrenalectomy Induced Hair Growth in Mink
- A Randomized, Multicenter, Evaluator-blind Study to Evaluate the Safety and Effectiveness of VYC-12L Treatment for Skin Quality Improvements
- Posters Presented at the 19th Joint Meeting of the International Society of Dermatopathology, March 2–3, 2016, Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia, USA
- Complications of Subcutaneous Contraception: A Review
- Hair-thread tourniquet syndrome: a case report and review of treatment
- Platelet-rich plasma and stem cells
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- Enhanced Effect of Platelet-Rich Plasma Containing a New Carrier on Hair Growth
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Systematic review of platelet‐rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability
- Studies on the persistence of estradiol benzoate and nortestosterone decanoate in hair of cattle following treatment with growth promoters, determined by ultra-high-performance liquid chromatography–tandem mass spectrometry
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Preparation of highly-concentrated autologous platelet-rich plasma for biomedical use
- A small dose of botulinum toxin A is effective for treating androgenetic alopecia in Chinese patients
- Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application
- The efficacy of subcutaneous slow‐release melatonin implants in the prevention of canine flank alopecia recurrence is uncertain: A double‐blind, randomized, placebo‐controlled study
- Applications of Ultrasound-Mediated Gene Delivery in Regenerative Medicine
- Use of artificial intelligence to track platelet-rich plasma treatment outcomes in females with nonscarring alopecia: A case series
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor